TITLE

The human genome leads back to BC

AUTHOR(S)
Kent, Heather
PUB. DATE
January 2001
SOURCE
CMAJ: Canadian Medical Association Journal;1/23/2001, Vol. 164 Issue 2, p312
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Profiles research scientist Marco Marra who works at the Genome Sequence Center at the British Columbia Cancer Agency. His works on projects involving the International Human Genome Project; His interest in endocrinology; How knowing a person's DNA sequence may influence the choice of drugs for a condition; Biographical information; Career Highlights.
ACCESSION #
4017823

 

Related Articles

  • British Columbia Cancer Agency Joins the Illumina Genome Network.  // Biomedical Market Newsletter;12/21/2011, Vol. 21, p1 

    The article presents information on an announcement made by Illumina Inc. on the joining of Genome Science Center of British Columbia Cancer Agency (BCCA) to the Illumina Genome Network (IGN). IGN is designed to link the researchers who need whole human genome sequencing with major institutions...

  • New device can detect skin cancer in seconds.  // South Asian Post;5/24/2012, p8 

    The article provides information on Verisante Aura, a device used for the diagnosis of melanoma, developed by the British Columbia Cancer Agency.

  • Radiation oncology.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS86 

    Presents an abstract of the research manuscript `Primary mucosal melanoma of nasal cavity, BCCA experience,' by R. Ma et al. British Columbia Cancer Agency (BCCA).

  • Medical Archiving to the Rescue.  // Health Management Technology;Aug2005, Vol. 26 Issue 8, p36 

    Highlights the information storage problems at the British Columbia Cancer Agency. Difficulty in the storage of cancer-related image files sent by the Provincial Health Services Authority to the agency; Selection of the HP Medical Archiving Solution system to solve the agency's storage...

  • Adenomyoepithelioma of the breast: a review stressing its propensity for malignant transformation. Hayes, Malcolm M. // Journal of Clinical Pathology;Jun2011, Vol. 64 Issue 6, p477 

    This review describes the classification, clinical presentation, pathological features and clinical behaviour of adenomyoepithelioma (AME) of the breast. It is based on an extensive review of the literature and study of a collection of cases built up over a 17-year period at the British Columbia...

  • BC Cancer Agency holds forum for lesbians. Sarra, Samantha // Xtra West (Vancouver);3/26/2009, Issue 407, p13 

    Information about several topics discussed at a forum by the British Columbia Cancer Agency for lesbians with cancer is presented. Topics include the lesbians' unique behaviours associated with higher cancer risks, gynaecologic oncology and maintenance of healthcare services such as mammography....

  • Computed Tomography Screening for Lung Cancer: What is a Positive Screen? Lam, Stephen; McWilliams, Annette; Mayo, John; Tammemagi, Martin // Annals of Internal Medicine;2/19/2013, Vol. 158 Issue 4, p289 

    The article focuses on study undertaken by the British Columbia Cancer Agency to study diagnosis of lung cancer. The U.S. National Institute of Health funded a National Lung Screening trial (NLST) to show that low dose of thoracic computed tomography has lowered the mortality rate due to Lung...

  • Verification of imatinib cost-effectiveness in advanced gastrointestinal stromal tumor in British Columbia (VINCE-BC study). Mabasa, Vincent H.; Taylor, Suzanne C. M.; Chu, Christina C. Y.; Moravan, Veronika; Johnston, Karissa; Peacock, Stuart; Knowling, Meg // Journal of Oncology Pharmacy Practice;Sep2008, Vol. 14 Issue 3, p105 

    Background. This cost-effectiveness analysis of imatinib in British Columbia Cancer Agency (BCCA) patients with advanced gastrointestinal stromal tumors (GIST) was performed to justify funding. Patients and Methods. A pragmatic, retrospective review identified BCCA patients with advanced GIST...

  • British Columbia Cancer Agency Selects RainDance's New ThunderStorm(tm) System for High-Throughput Targeted Sequencing of Cancer Predisposition Genes.  // Biomedical Market Newsletter;11/21/2011, Vol. 21, p265 

    The article reports that the British Columbia Cancer Agency has purchased the ThunderStorm System from RainDance Technologies Inc. It mentions that the British Columbia Cancer Agency aims to sequence a substantial number of cancer predisposition genes. It notes that the ThunderStorm System is an...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics